LATS2 mRNA expression in BLCA (urothelial bladder carcinoma), BRCA (invasive breast carcinoma), KICH (kidney chromophobe), LUAD (lung adenocarcinoma), LUSC (lung squamous cell carcinoma), and THCA (thyroid carcinoma) was lower than that in the normal tissues. Here, LATS2 is linked to invasive breast carcinoma.